| Members |
targetComponentId |
| Mixed cell type lymphosarcoma of lymph nodes of inguinal region and lower limb |
Malignant lymphoma of lymph nodes of lower limb (disorder) |
| Mixed cell type lymphosarcoma of lymph nodes of multiple sites |
Malignant lymphoma of lymph nodes |
| Mixed cell type lymphosarcoma of spleen |
Non-Hodgkin's lymphoma (clinical) |
| blandad könscell-könssträng-stromacellstumör |
Mixed germ cell-sex cord-stromal tumor (morphologic abnormality) |
| Mixed renal tubular acidosis |
Renal tubular acidosis |
| Mixtard insulin adverse reaction |
Insulin adverse reaction |
| Mixtard insulin allergy |
Allergy to insulin |
| Moderate asthma |
Moderate asthma |
| måttlig mittlinjeförskjutning av överkäkens tänder åt vänster |
Moderate midline deviation of maxillary dental arch to left (finding) |
| måttlig mittlinjeförskjutning av överkäkens tänder åt höger |
Moderate midline deviation of maxillary dental arch to right |
| allergi mot isosorbiddinitrat med modifierad frisättning |
Allergy to isosorbide (finding) |
| allergi mot isosorbidmononitrat med modifierad frisättning |
Allergy to isosorbide (finding) |
| Moeller's glossitis |
Atrophy of tongue papillae |
| Mohs' chemosurgery, fresh tissue technique |
Mohs' chemosurgery |
| molgramostim 300 mikrogram, pulver till injektionsvätska, flaska |
Product containing only molgramostim in parenteral dose form (medicinal product form) |
| molindonhydroklorid 20 mg/ml |
Product containing only molindone (medicinal product) |
| Molluscum contagiosum subgroup virus |
Genus Molluscipoxvirus (organism) |
| Molluscum contagiosum with eyelid involvement |
Infection of skin of eyelid caused by Molluscum contagiosum (disorder) |
| Molluscum contagiosum som involverar ögonlocken |
Infection of skin of eyelid caused by Molluscum contagiosum (disorder) |
| Mollusk |
Phylum Mollusca (organism) |
| blötdjur, livsmedel |
Marine mollusk (substance) |
| mometasonfuroat 200 mikrogram, lockaktiverad pulverinhalator |
Product containing only mometasone in pulmonary dose form (medicinal product form) |
| monoartikulär juvenil reumatoid artrit |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| övervakning av drogabstinens |
Monitoring substance withdrawal |
| Monitoring of cardiac output by other technique |
Monitoring of cardiac output/cardiac index |
| Monitoring of pressure in organ NOC |
Physiological monitoring regime (regime/therapy) |
| Monitoring patient temperature by nurse |
Monitoring of patient temperature |
| Monoarticular juvenile rheumatoid arthritis |
Juvenile idiopathic arthritis, oligoarthritis (disorder) |
| Monoclonal gammopathy |
Monoclonal gammopathy of undetermined significance |
| monoklonalt genrearrangemang |
T cell gene rearrangement analysis (procedure) |
| Monocytic leukemia in remission |
Myeloid leukemia in remission |
| Monocytoid B-cell lymphoma |
Marginal zone B-cell lymphoma |
| Monooxygenase |
Monooxygenase (substance) |
| Monosporium apiospermum |
Scedosporium boydii |
| Monster NOS |
Congenital malformation |
| missbildat foster med kranieanomalier |
Congenital anomaly of skull |
| Monstrocellular sarcoma |
Giant cell glioblastoma |
| Montelukast sodium 4mg oral granules |
Product containing precisely montelukast (as montelukast sodium) 4 milligram/1 sachet conventional release oral granules (clinical drug) |
| program för verbal rörlighet enligt Monterey |
Monterey Fluency Program (regime/therapy) |
| alkoholutlöst förstämningssyndrom |
Mood disorder caused by ethanol (disorder) |
| förstämningssyndrom med depressionssymtom orsakat av alkohol |
Mood disorder with depressive symptoms caused by ethanol |
| förstämningssyndrom med manisymtom orsakat av alkohol |
Mood disorder with manic symptoms caused by ethanol (disorder) |
| förstämningssyndrom med blandade mani- och depressionssymtom orsakat av alkohol |
Mood disorder with mixed manic and depressive symptoms caused by ethanol |
| Moraxella (Moraxella) phenylpyruvica |
Psychrobacter phenylpyruvicus |
| Moraxella anatipestifer |
Riemerella anatipestifer |
| hostdämpande morfinanpreparat |
Morphinan opioid |
| biverkning av hostdämpande morfinanpreparat |
Morphinan opioid adverse reaction |
| allergi mot hostdämpande morfinanpreparat |
Allergy to morphinan opioid |
| morfin, icke läkemedel |
Morphine (substance) |
| morfinhydroklorid 10 mg/ml, oral lösning |
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| morfinsulfat 100 mg + naltrexonhydroklorid 4 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 100 mg + naltrexonhydroklorid 4 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 100 mg, rektaltampong |
Morphine sulfate 100 mg rectal suppository |
| morfinsulfat, granulat till suspension, dospåse 100 mg |
Product containing precisely morphine sulfate 5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| morfinsulfat 10 mg/ml, liposominjektionspreparat med förlängd frisättning |
Morphine sulfate liposome 10 mg/mL solution for injection |
| morfinsulfat, granulat till suspension, dospåse 200 mg |
Product containing precisely morphine sulfate 6.67 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| morfinsulfat 20 mg + naltrexonhydroklorid 800 mikrogram, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 20 mg + naltrexonhydroklorid 800 mikrogram, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat, granulat till suspension, dospåse 20 mg |
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| morfinsulfat 30 mg + naltrexonhydroklorid 1,2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 30 mg + naltrexonhydroklorid 1,2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 30 mg/5 ml, endosflaska för oralt bruk |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| morfinsulfat, granulat till suspension, dospåse 30 mg |
Morphine sulfate 3 mg/mL oral suspension |
| morfinsulfat 35 mg, rektaltampong |
Morphine sulfate 35 mg rectal suppository |
| morfinsulfat 50 mg + naltrexonhydroklorid 2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 50 mg + naltrexonhydroklorid 2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 50 mg, rektaltampong |
Morphine sulfate 50 mg rectal suppository |
| morfinsulfat 60 mg + naltrexonhydroklorid 2,4 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 60 mg + naltrexonhydroklorid 2,4 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat, granulat till suspension, dospåse 60 mg |
Product containing precisely morphine sulfate 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| morfinsulfat 75 mg, rektaltampong |
Morphine sulfate 75 mg rectal suppository |
| morfinsulfat 80 mg + naltrexonhydroklorid 3,2 mg, kapsel med modifierad frisättning |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 80 mg + naltrexonhydroklorid 3,2 mg, depåkapsel |
Product containing only morphine and naltrexone in oral dose form (medicinal product form) |
| morfinsulfat 80 mg, kapsel med modifierad frisättning |
Product containing only morphine in oral dose form (medicinal product form) |
| morfinsulfat 80 mg, depåkapsel |
Product containing only morphine in oral dose form (medicinal product form) |
| Morphine tartrate+cyclizine |
Product containing cyclizine and morphine (medicinal product) |
| Morphinian antitussive agent |
Morphinan opioid |
| Mosquito-borne bunyavirus encephalitis |
Mosquito-borne orthobunyavirus encephalitis |
| Mosquito-borne bunyavirus fever |
Mosquito-borne orthobunyavirus fever |
| ammar för närvarande |
Mother currently breastfeeding |
| Mother currently breast-feeding |
Mother currently breastfeeding |
| moder till patienten |
Mother |
| Mouse mammary tumor virus |
Mouse mammary tumor virus |
| flyttat annorstädes |
Moved elsewhere |
| Moxifloxacin hydrochloride |
Product containing moxifloxacin (medicinal product) |
| moxifloxacinhydroklorid 0,5 %, lösning för oftalmiskt bruk |
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| moxifloxacinhydroklorid 1,6 mg/ml, infusionsvätska, lösning, påse 250 ml |
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection |
| Mucinous cystadenoma, borderline malignancy |
Mucinous cystic tumor of borderline malignancy |
| mucinös cystisk tumör med måttlig dysplasi |
Mucinous cystadenoma |
| Mucoid otitis media |
Chronic mucoid otitis media |
| biverkning av mukolytika |
Adverse reaction to drug |
| Mucosal-associated lymphoid tissue (MALT) lymphoma |
Marginal zone B-cell lymphoma |
| mukosit som följd av cytostatikabehandling |
Inflammation of mucous membrane due to and following chemotherapy |
| antiinfektivt medel för slemhinna |
Anti-infective agent (substance) |
| Mulberry molar |
Moon's molar teeth |
| multe eller mulle, livsmedel |
Mullet (substance) |
| Multiceps |
Taenia |
| Multiceps |
Taenia |
| Multiceps brauni |
Taenia brauni |
| Multiceps serialis |
Taenia serialis (organism) |
| polycystisk njursjukdom |
Multicystic renal dysplasia |
FHIR